Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia
- Status
- COMPLETED
- Phase
- PHASE2
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Chemotherapy for Lung Cancer in HIV-positive Patients
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)
- Status
- COMPLETED
- Phase
- PHASE3
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Intermittent Versus Continuous Tarceva Study
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)
- Status
- COMPLETED
- Phase
- N/A
Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
PET-CT and Circulating Tumor Cells in Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
- Status
- COMPLETED
- Phase
- PHASE3
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)
- Status
- TERMINATED
- Phase
- PHASE2